
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16842866
[patent_doc_number] => 11014940
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-05-25
[patent_title] => Thiazolidinone and oxazolidinone compounds and formulations
[patent_app_type] => utility
[patent_app_number] => 16/653223
[patent_app_country] => US
[patent_app_date] => 2019-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17985
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16653223
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/653223 | Thiazolidinone and oxazolidinone compounds and formulations | Oct 14, 2019 | Issued |
Array
(
[id] => 17953465
[patent_doc_number] => 11479556
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-10-25
[patent_title] => Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
[patent_app_type] => utility
[patent_app_number] => 15/734774
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74710
[patent_no_of_claims] => 106
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734774 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | Oct 13, 2019 | Issued |
Array
(
[id] => 16985450
[patent_doc_number] => 11072606
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Compositions and methods for treating diseases and conditions
[patent_app_type] => utility
[patent_app_number] => 16/600248
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19839
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/600248 | Compositions and methods for treating diseases and conditions | Oct 10, 2019 | Issued |
Array
(
[id] => 18085500
[patent_doc_number] => 11535618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/282521
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26968
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 803
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282521
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282521 | Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors | Oct 3, 2019 | Issued |
Array
(
[id] => 16168136
[patent_doc_number] => 10709675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Nutraceutical compositions comprising C60 and curcumin
[patent_app_type] => utility
[patent_app_number] => 16/589715
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1429
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/589715 | Nutraceutical compositions comprising C60 and curcumin | Sep 30, 2019 | Issued |
Array
(
[id] => 15865961
[patent_doc_number] => 20200140384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => MODULATORS OF HEMOGLOBIN
[patent_app_type] => utility
[patent_app_number] => 16/588753
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16588753
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/588753 | Modulators of hemoglobin | Sep 29, 2019 | Issued |
Array
(
[id] => 17875497
[patent_doc_number] => 11447498
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Fused tetracyclic compounds and uses thereof in medicine
[patent_app_type] => utility
[patent_app_number] => 17/276735
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34287
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 923
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276735 | Fused tetracyclic compounds and uses thereof in medicine | Sep 26, 2019 | Issued |
Array
(
[id] => 15363417
[patent_doc_number] => 20200017473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => AMIDE-SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/579341
[patent_app_country] => US
[patent_app_date] => 2019-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16579341
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/579341 | Amide-substituted pyridinyltriazole derivatives and uses thereof | Sep 22, 2019 | Issued |
Array
(
[id] => 15586337
[patent_doc_number] => 20200069703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/578130
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16578130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/578130 | CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE | Sep 19, 2019 | Abandoned |
Array
(
[id] => 16238174
[patent_doc_number] => 20200255408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/575724
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16575724
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/575724 | INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF | Sep 18, 2019 | Abandoned |
Array
(
[id] => 17228578
[patent_doc_number] => 20210355134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2
[patent_app_type] => utility
[patent_app_number] => 17/280632
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280632
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280632 | Manufacture of compounds and compositions for inhibiting the activity of SHP2 | Sep 17, 2019 | Issued |
Array
(
[id] => 15586341
[patent_doc_number] => 20200069705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => NOVEL PARASITE THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/564773
[patent_app_country] => US
[patent_app_date] => 2019-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16564773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/564773 | Parasite therapy | Sep 8, 2019 | Issued |
Array
(
[id] => 17214406
[patent_doc_number] => 20210347743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Processes for Preparing a MDM2 Inhibitor
[patent_app_type] => utility
[patent_app_number] => 17/272031
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17272031
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/272031 | Processes for preparing a MDM2 inhibitor | Aug 29, 2019 | Issued |
Array
(
[id] => 15267215
[patent_doc_number] => 20190382341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => BISMALEIMIDE AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/555675
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555675 | BISMALEIMIDE AND METHOD FOR PRODUCING THE SAME | Aug 28, 2019 | Abandoned |
Array
(
[id] => 17006996
[patent_doc_number] => 20210238157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => Novel Cannabinoids and Cannabinoid Acids and Their Derivatives
[patent_app_type] => utility
[patent_app_number] => 17/269732
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269732 | Cannabinoids and cannabinoid acids and their derivatives | Aug 19, 2019 | Issued |
Array
(
[id] => 15496225
[patent_doc_number] => 20200048301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => EPOXY-(METH)ACRYLATE MONOMERS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/538989
[patent_app_country] => US
[patent_app_date] => 2019-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16538989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/538989 | Epoxy-(meth)acrylate monomers and polymers and methods of making and using the same | Aug 12, 2019 | Issued |
Array
(
[id] => 16869955
[patent_doc_number] => 20210163422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => REAGENTS BASED ON A TERTIARY AMINE BACKBONE TO INTRODUCE CHEMICAL FUNCTIONALITY IN NUCLEIC ACIDS AND SEQUENCE-CONTROLLED POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/263243
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263243
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263243 | Reagents based on a tertiary amine backbone to introduce chemical functionality in nucleic acids and sequence-controlled polymers | Aug 8, 2019 | Issued |
Array
(
[id] => 15454339
[patent_doc_number] => 20200039994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => HETEROARYL AMIDE COMPOUNDS AS STING ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/528062
[patent_app_country] => US
[patent_app_date] => 2019-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 3612
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16528062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/528062 | Heteroaryl amide compounds as sting activators | Jul 30, 2019 | Issued |
Array
(
[id] => 15435149
[patent_doc_number] => 20200031758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => CRYSTALLINE EPINEPHRINE MALONATE SALT
[patent_app_type] => utility
[patent_app_number] => 16/526286
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526286 | Crystalline epinephrine malonate salt | Jul 29, 2019 | Issued |
Array
(
[id] => 17905455
[patent_doc_number] => 11459298
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Class of dicationic compounds as well as the preparative method and the use thereof
[patent_app_type] => utility
[patent_app_number] => 17/044520
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4283
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044520 | Class of dicationic compounds as well as the preparative method and the use thereof | Jul 23, 2019 | Issued |